Peter Besmer

20.2k citations

119 papers · 16.6k indexed · 8 hit papers · h-index 65

Gastroenterology top 0.05%
- Gastrointestinal Tumor Research and Treatment 33
Immunology and Allergy top 0.2%
- Cell Adhesion Molecules Research 11
Immunology top 0.2%
- Mast cells and histamine 26
Hematology top 0.2%
- Platelet Disorders and Treatments 14
- Chronic Myeloid Leukemia Treatments 11
Reproductive Medicine top 0.5%
Pulmonary and Respiratory Medicine
- Sarcoma Diagnosis and Treatment 20
Genetics
- Virus-based gene therapy research 18
Molecular Biology
- PI3K/AKT/mTOR signaling in cancer 9

Co-authors: Cristina R. Antonescu Eric J. Huang Rosemary F. Bachvarova Benoı̂t Chabot Alan Bernstein K Nocka Ronald P. DeMatteo Karl Nocka
Cited by: Gastroenterology Immunology and Allergy Immunology
Journals: Clinical Cancer Research (9 papers)Journal of Virology (9 papers)Proceedings of the National Academy of Sciences (8 papers)
Partner nations: United States Canada Japan

In The Last Decade

Peter Besmer

117 papers receiving 16.1k citations

Hit Papers

8 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2011 Nature Medicine
2005 Clinical Cancer Research
2002 Cell
1990 The EMBO Journal
1990 Cell
1988 Nature
1988 The EMBO Journal
1986 Nature

Peers

Countries citing papers authored by Peter Besmer

Since Specialization

Citations

This map shows the geographic impact of Peter Besmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Besmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Besmer more than expected).

Fields of papers citing papers by Peter Besmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Besmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Besmer. The network helps show where Peter Besmer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Besmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Besmer Line = papers co-authored together Peter Besmer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor Molecular Cancer Therapeutics ·Shan Zeng,Adrian M. Seifert,Jennifer Q. Zhang,Michael J. Cavnar,Teresa S. Kim,Vinod P. Balachandran,Juan A. Santamaria‐Barria,Noah A. Cohen,Michael J. Beckman,Benjamin D. Medina,Ferdinand Rossi,Megan H. Crawley,Jennifer K. Loo,Joanna H. Maltbaek,Peter Besmer,Cristina R. Antonescu,Ronald P. DeMatteo	2017	31
2	Direct engagement of the PI3K pathway by mutant KIT dominates oncogenic signaling in gastrointestinal stromal tumor Proceedings of the National Academy of Sciences ·Benedikt Bosbach,Ferdinand Rossi,Lulu Qiu,Jennifer K. Loo,Jennifer Q. Zhang,Georgina Berrozpe,Lenin Humberto,Imke Ehlers,Darren R. Veach,Andrew Kwok,Katia Manova,Cristina R. Antonescu,Ronald P. DeMatteo,Peter Besmer	2017	37
3	PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors Clinical Cancer Research ·Adrian M. Seifert,Shan Zeng,Jennifer Q. Zhang,Teresa S. Kim,Noah A. Cohen,Michael J. Beckman,Benjamin D. Medina,Joanna H. Maltbaek,Jennifer K. Loo,Megan H. Crawley,Ferdinand Rossi,Peter Besmer,Cristina R. Antonescu,Ronald P. DeMatteo	2016	117
4	A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitors Nature Cell Biology ·Mario Buono,R Facchini,Sahoko Matsuoka,Supat Thongjuea,Dominic Waithe,Tiago C. Luís,Alice Giustacchini,Peter Besmer,Adam J. Mead,Sten Eirik W. Jacobsen,Claus Nerlov	2016	49
5	Combined Inhibition of MAP Kinase and KIT Signaling Synergistically Destabilizes ETV1 and Suppresses GIST Tumor Growth Cancer Discovery ·Leili Ran,Inna Sirota,Zhen Cao,Devan Murphy,Yuedan Chen,Shipra Shukla,Yuanyuan Xie,Christian Brannstrom,Dong Gao,Sinan Zhu,Ferdinando Rossi,John Wongvipat,Takahiro Taguchi,William D. Tap,Ingo K. Mellinghoff,Peter Besmer,Cristina R. Antonescu,Yu Chen,Ping Chi	2015	93
6	Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor Clinical Cancer Research ·Teresa S. Kim,Michael J. Cavnar,Noah A. Cohen,Eric C. Sorenson,Jonathan B. Greer,Adrian M. Seifert,Megan H. Crawley,Benjamin L. Green,Rachel Popow,Nagavarakishore Pillarsetty,Darren R. Veach,Anson T. Ku,Ferdinand Rossi,Peter Besmer,Cristina R. Antonescu,Shan Zeng,Ronald P. DeMatteo	2014	44
7	KIT oncogene inhibition drives intratumoral macrophage M2 polarization The Journal of Experimental Medicine ·Michael J. Cavnar,Shan Zeng,Teresa S. Kim,Eric C. Sorenson,Lee M. Ocuin,Vinod P. Balachandran,Adrian M. Seifert,Jonathan B. Greer,Rachel Popow,Megan H. Crawley,Noah A. Cohen,Benjamin L. Green,Ferdinand Rossi,Peter Besmer,Cristina R. Antonescu,Ronald P. DeMatteo	2013	101
8	The Expression of the Glucocorticoid Receptor in Human Erythroblasts is Uniquely Regulated by KIT Ligand: Implications for Stress Erythropoiesis Stem Cells and Development ·Lilian Varricchio,Valentina Tirelli,Elena Masselli,Barbara Ghinassi,Nayanendu Saha,Peter Besmer,Anna Ritá Migliaccio	2012	23
9	IGF1 promotes survival of mast cells and regulates their number in the developing mammary gland CINECA IRIS Institutial Research Information System (University of Genoa) ·Pietro Ameri,Yılmaz Yozgat,W Ruan,Giovanni Murialdo,Peter Besmer,Diego Ferone,D L Kleinberg	2011	0
10	Mechanisms of Sunitinib Resistance in Gastrointestinal Stromal Tumors Harboring KIT AY502-3ins Mutation: An In vitro Mutagenesis Screen for Drug Resistance Clinical Cancer Research ·Tianhua Guo,Junianto,Narasimhan P. Agaram,Yuxin Guo,Darren R. Veach,Bayard D. Clarkson,Robert G. Maki,Samuel Singer,Ronald P. DeMatteo,Peter Besmer,Cristina R. Antonescu	2009	69
11	Kit ligand cytoplasmic domain is essential for basolateral sorting in vivo and has roles in spermatogenesis and hematopoiesis Developmental Biology ·Shayu Deshpande,Valter Agosti,Katia Manova,Malcolm A.S. Moore,Matthew P. Hardy,Peter Besmer	2009	13
12	Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors Clinical Cancer Research ·Narasimhan P. Agaram,Michael P. LaQuaglia,Berrin Ustun,Tianhua Guo,Si-Ming Dai,Nicholas D. Socci,Robert G. Maki,Ronald P. DeMatteo,Peter Besmer,Cristina R. Antonescu	2008	187
13	Histone H2AX Is a Mediator of Gastrointestinal Stromal Tumor Cell Apoptosis following Treatment with Imatinib Mesylate Cancer Research ·Ying Liu,Michelle Tseng,Marta Dmitruk,Ferdinand Rossi,Cristina R. Antonescu,Peter Besmer,Jonathan A. Fletcher,Stefan Duensing,Anette Duensing	2007	73
14	Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST) Cancer ·Ronald P. DeMatteo,Jason S. Gold,Simone Nübling,Mithat Gönen,Kui Hin Liau,Robert G. Maki,Samuel Singer,Peter Besmer,Murray F. Brennan,Cristina R. Antonescu	2007	386
15	The Scaffolding Adapter Gab2, via Shp-2, Regulates Kit-evoked Mast Cell Proliferation by Activating the Rac/JNK Pathway Journal of Biological Chemistry ·Min Yu,Jincai Luo,Wentian Yang,Yongping Wang,Masao Mizuki,Yuzuru Kanakura,Peter Besmer,Benjamin G. Neel,Haihua Gu	2006	68
16	Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligandbreakdown → Cell ·Beate Heissig,Koichi Hattori,Sérgio Dias,Matthias Friedrich,Barbara Ferris,Neil R. Hackett,Ronald G. Crystal,Peter Besmer,David Lyden,Malcolm A.S. Moore,Zena Werb,Shahin Rafii	2002	1367
17	c-kit receptor signaling through its phosphatidylinositide-3'-kinase-binding site and protein kinase C: role in mast cell enhancement of degranulation, adhesion, and membrane ruffling. Molecular Biology of the Cell ·Keith Vosseller,Giulia Maria Stella,Nelson S. Yee,Peter Besmer	1997	94
18	The Ligand of the c-kit Receptor Promotes Oocyte Growth Developmental Biology ·Alan Packer,Ying Hsu,Peter Besmer,Rosemary F. Bachvarova	1994	205
19	Transmeiotic differentiation of male germ cells in culture Cell ·Minoo Rassoulzadegan,Véronique Paquis‐Flucklinger,Béatrice Bertino,Julien Sage,Maria Jasin,Kiyoshi Miyagawa,Veronica van Heyningen,Peter Besmer,François Cuzin	1993	147
20	Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Molecular Biology of the Cell ·Eric J. Huang,K Nocka,Jochen Buck,Peter Besmer	1992	276

About Peter Besmer

Peter Besmer is a scholar working on Gastroenterology, Hematology and Immunology, having authored 119 papers that have together received 16.6k indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (33 papers), Mast cells and histamine (26 papers), Sarcoma Diagnosis and Treatment (20 papers), Virus-based gene therapy research (18 papers), Platelet Disorders and Treatments (14 papers), Chronic Myeloid Leukemia Treatments (11 papers), Cell Adhesion Molecules Research (11 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). The work is most often cited by research in Gastroenterology (3.5k citations), Immunology and Allergy (1.4k citations) and Immunology (4.8k citations). Peter Besmer has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Cristina R. Antonescu, Eric J. Huang, Rosemary F. Bachvarova, Benoı̂t Chabot, Alan Bernstein, K Nocka, Ronald P. DeMatteo, Karl Nocka, Jochen Buck and Dennis A. Stephenson. Their work appears in journals such as Clinical Cancer Research, Journal of Virology, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact